ANAVEX LIFE SCIENCES CORP. Net Income (Loss) Available to Common Stockholders, Basic
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Net Income (Loss) Available to Common Stockholders, Basic of $7.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was $7.82M.
- ANAVEX LIFE SCIENCES CORP. net income (loss) available to common stockholders, basic for the quarter ending 2025-06-30 was -$13.24M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month |
|---|---|---|
| 2026-06-30 | $7.82M 10-Q · filed 2026-08-28 | -$3.18M 10-Q · filed 2026-08-28 |
| 2025-06-30 | -$13.24M 10-Q · filed 2026-08-28 | -$36.55M 10-Q · filed 2026-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |